Brain cancer drug update confirms exquisite targeting & promising …

Cotara has been granted orphan drug status and fast track designation for the treatment of glioblastoma multiforme and anaplastic astrocytoma by the U.S. Food and Drug Administration. A Phase I dosimetry trial in GBM patients in the …

Read the original:
Brain cancer drug update confirms exquisite targeting & promising …

Share/Save/Bookmark

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment